| payload |
{"created_at":"2026-04-20T17:15:12.787 {"created_at":"2026-04-20T17:15:12.787981+00:00","signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/why-compass-pathways-stock-rocketed-40-today","value":{"fp":"f02be8d4f1a08f91","kind":"unusual_volume","published_at":"2026-04-20T16:22:35+00:00","source":"Nasdaq Markets","summary":"Key PointsCompass Pathways has already reported two positive phase 3 trials for treatment-resistant depression (TRD).","tickers":["TRD"],"title":"Why Compass Pathways Stock Rocketed 40% Today","url":"https://www.nasdaq.com/articles/why-compass-pathways-stock-rocketed-40-today"}}... |